AkomaCare vs SpectraRIS Usage & Stats

Cardiovascular diseases (CVDs) are a growing public health problem in Ghana and other African countries. Strokes and other CVDs have become a leading cause of death due to increasing risk factors such as hypertension. According to the Global Burden of Disease study (GBD), ischaemic heart disease was the fourth leading cause of death in Ghana in 2016. The prevalence of hyper- tension, a major risk factor for CVDs, is increasing rapidly and ranges from 19% to 48%, according to the Ghana Health Service Annual Report, 2017, due to rising life expectancy and the increasing prevalence of contributing factors such as overweight/obesity. Early diagnosis and adequate management of the risk factors can reduce the fatal consequences of CVDs. At the heart of improving risk assessment and management of CVDs are nationally approved guidelines, which facilitate standardisation of care approaches. These guidelines developed by experts from all levels of health care and stakeholders together capture all recommended approaches and necessary information for clinicians and other healthcare workers on CVDs. They also serve as a practical guide for assessing and managing the most important CVDs prevalent in Ghana and can be used at all the levels of care namely health facilities without a doctor; with a general practitioner and with a physician specialist. We hope that these guidelines will prove to be a useful and a beneficial tool for all its users.
  • Apple App Store
  • Free
  • Medical

Store Rank

- -

Welcome to SpectraRIS, your all-in-one solution for efficient radiology appointment management and seamless access to diagnostic reports. SpectraRIS is a cutting-edge application designed to empower medical professionals and patients with comprehensive tools for scheduling appointments, tracking progress, and accessing radiological reports securely. Key Features: Appointment Management Made Simple: Easily create, reschedule, or cancel appointments for patients with just a few taps. Intuitive calendar view provides a clear overview of appointment schedules, ensuring efficient time management. Real-Time Status Tracking: Stay updated on the status of each appointment in real-time, from scheduling to report generation. Receive instant notifications for appointment changes or updates to stay informed at all times. Instant Radiological Report Access: Access radiological reports as soon as they are generated, ensuring timely diagnosis and treatment planning. Reports are securely stored within the app, accessible anytime, anywhere. Patient-Centric Portal: Patients can log in securely to access their appointment details and radiological reports. Ensure patient confidentiality and convenience with easy-to-use authentication and navigation. Seamless Communication Channels: Foster smooth communication between healthcare providers and patients through built-in messaging features. Address patient inquiries, provide explanations, or offer further instructions directly within the app. User-Friendly Interface: SpectraRIS boasts an intuitive interface designed for ease of use by both medical professionals and patients. Navigate effortlessly through the app's functionalities to maximize productivity and enhance patient care. SpectraRIS revolutionizes radiology management by streamlining appointment scheduling, providing real-time updates, and facilitating instant access to critical diagnostic reports. Experience the future of radiology management—download SpectraRIS now and elevate your practice to new heights of efficiency and patient care excellence.
  • Apple App Store
  • Free
  • Health & Fitness

Store Rank

- -

AkomaCare vs. SpectraRIS ranking comparison

Compare AkomaCare ranking trend in the past 28 days vs. SpectraRIS

Rank

No Data Available

AkomaCare vs. SpectraRIS ranking by country comparison

Compare AkomaCare ranking trend in the past 28 days vs. SpectraRIS

All categories

No Data Available

Medical

App
Top Country
Rank
#40
- -
- -

Compare to any site with our free trial

Get started
AkomaCare VS.
SpectraRIS

December 10, 2024